Miguel Risco, MD, from UC-Irvine Department of Hematology and Oncology joins us at MOASCs Spotlight On® Hematology in Huntington Beach to talk about the safety of chronic lymphocytic leukemia combination therapy and the fair number of hematologic & non-hematologic adverse effects.
Safety of Chronic Lymphocytic Leukemia Combination Therapy – Fair Number of Hematologic & Non-Hematologic Adverse Effects
